Glaukos Corporation

93.95+2.20+2.40%Vol 30.71K1Y Perf 168.34%
Apr 23rd, 2021 11:00 DELAYED
BID93.89 ASK94.23
Open92.19 Previous Close91.75
Pre-Market- After-Market-
 - -%  - -
Target Price
79.22 
Analyst Rating
Hold 2.67
Potential %
-15.84 
Finscreener Ranking
★★★     50.03
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     53.80
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     45.21
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap4.30B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
92.22 
Earnings Date
5th May 2021

Today's Price Range

92.1994.22

52W Range

34.1099.00

5 Year PE Ratio Range

-1 992.00437.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
7.92%
1 Month
8.80%
3 Months
5.25%
6 Months
57.51%
1 Year
168.34%
3 Years
202.71%
5 Years
397.29%
10 Years
-

TickerPriceChg.Chg.%
GKOS93.952.20002.40
AAPL133.701.76001.33
GOOG2 295.6127.69001.22
MSFT259.672.50000.97
XOM55.830.56001.01
WFC43.650.95002.22
JNJ165.860.68000.41
FB298.842.32000.78
GE13.550.14001.04
JPM149.792.42001.64
ValuationValueIndustryS&P 500US Markets
-31.40
5.83
22.68
86.40
-242.70
-0.52
15.98
14.58
3.76B
Forward PE-126.89
PEG13.48
Financial StrengthValueIndustryS&P 500US Markets
8.90
9.40
0.29
0.41
-8.40
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
59.20
-63.70
-49.70
-16.60
-36.94
RevenueValueIndustryS&P 500US Markets
169.62M
3.70
13.04
23.81
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.32-0.0293.75
Q03 2020-0.46-0.0980.43
Q02 2020-0.78-0.6121.79
Q01 2020-0.35-0.44-25.71
Q04 2019-0.17-0.0664.71
Q03 2019-0.17-0.1041.18
Q02 2019-0.10-0.11-10.00
Q01 2019-0.12-0.0466.67
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.3018.92Positive
6/2021 QR-0.309.09Positive
12/2021 FY-1.063.64Positive
12/2022 FY-0.675.63Positive
Next Report Date5th May 2021
Estimated EPS Next Report-0.30
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume30.71K
Shares Outstanding45.79M
Trades Count601
Dollar Volume39.70M
Avg. Volume420.23K
Avg. Weekly Volume278.03K
Avg. Monthly Volume399.12K
Avg. Quarterly Volume400.64K

Glaukos Corporation (NYSE: GKOS) stock closed at 91.75 per share at the end of the most recent trading day (a 1.3% change compared to the prior day closing price) with a volume of 260.18K shares and market capitalization of 4.30B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 600 people. Glaukos Corporation CEO is Thomas W. Burns.

The one-year performance of Glaukos Corporation stock is 168.34%, while year-to-date (YTD) performance is 21.91%. GKOS stock has a five-year performance of 397.29%. Its 52-week range is between 34.1 and 99, which gives GKOS stock a 52-week price range ratio of 92.22%

Glaukos Corporation currently has a PE ratio of -31.40, a price-to-book (PB) ratio of 5.83, a price-to-sale (PS) ratio of 22.68, a price to cashflow ratio of 86.40, a PEG ratio of 2.32, a ROA of -12.69%, a ROC of -11.44% and a ROE of -17.19%. The company’s profit margin is -36.94%, its EBITDA margin is -49.70%, and its revenue ttm is $169.62 Million , which makes it $3.70 revenue per share.

Of the last four earnings reports from Glaukos Corporation, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Glaukos Corporation’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Glaukos Corporation is Hold (2.67), with a target price of $79.22, which is -15.84% compared to the current price. The earnings rating for Glaukos Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Glaukos Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Glaukos Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 13.85, ATR14 : 3.83, CCI20 : 269.96, Chaikin Money Flow : 0.02, MACD : -0.54, Money Flow Index : 52.51, ROC : 12.25, RSI : 58.43, STOCH (14,3) : 90.51, STOCH RSI : 1.00, UO : 61.68, Williams %R : -9.49), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Glaukos Corporation in the last 12-months were: Chris M. Calcaterra (Option Excercise at a value of $996 276), Chris M. Calcaterra (Sold 60 417 shares of value $5 339 776 ), Joseph E. Gilliam (Option Excercise at a value of $728 350), Joseph E. Gilliam (Sold 18 750 shares of value $1 767 336 ), Thomas W. Burns (Option Excercise at a value of $825 397), Thomas W. Burns (Sold 207 847 shares of value $8 152 748 ), William J. Link (Option Excercise at a value of $1 243 100), William J. Link (Sold 50 000 shares of value $3 398 322 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (44.44 %)
4 (44.44 %)
4 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (22.22 %)
2 (22.22 %)
3 (30.00 %)
Moderate Sell
1 (11.11 %)
1 (11.11 %)
1 (10.00 %)
Strong Sell
2 (22.22 %)
2 (22.22 %)
2 (20.00 %)
Summary RatingHold
2.67
Hold
2.67
Hold
2.70

Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

CEO: Thomas W. Burns

Telephone: +1 949 367-9600

Address: 229 Avenida Fabricante, San Clemente 92672, CA, US

Number of employees: 600

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

49%51%

Bearish Bullish

58%42%

News

Stocktwits